Cladribine tablets produce selective and discontinuous reduction of B and T lymphocytes and natural killer cells in patients with early and relapsing Multiple Sclerosis

Category Primary study
JournalEuropean Journal of Neurology
Year 2018
This article has no abstract
Epistemonikos ID: 6346fdb107f5d58197177c53a52753016b580d5c
First added on: Feb 09, 2025